نتایج جستجو برای: xanthohumol

تعداد نتایج: 254  

2017
Birgit M Dietz Shao-Nong Chen René F Ramos Alvarenga Huali Dong Dejan Nikolić Martin Biendl Richard B van Breemen Judy L Bolton Guido F Pauli

Botanical dietary supplements contain multiple bioactive compounds that target numerous biological pathways. The lack of uniform standardization requirements is one reason that inconsistent clinical effects are reported frequently. The multifaceted biological interactions of active principles can be disentangled by a coupled pharmacological/phytochemical approach using specialized ("knock-out")...

Journal: :Biochimica et biophysica acta 2014
Olga Wesołowska Justyna Gąsiorowska Joanna Petrus Bogusława Czarnik-Matusewicz Krystyna Michalak

Common hop (Humulus lupulus) constitutes a source of numerous prenylated chalcones such as xanthohumol (XH) and flavanones such as 8-prenylnaringenin (8-PN) and isoxanthohumol (IXH). Range of their biological activities includes estrogenic, anti-inflammatory, anti-infective, anti-cancer, and antioxidant activities. The aim of the present work was to characterize the influence of prenylated poly...

2012
Ewelina Szliszka Dagmara Jaworska Małgorzata Kłósek Zenon P. Czuba Wojciech Król

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in cancer cells without toxicity to normal cells. TRAIL binds to death receptors, TRAIL-R1 (DR4) and TRAIL-R2 (DR5) expressed on cancer cell surface and activates apoptotic pathways. Endogenous TRAIL plays an important role in immune surveillance and defense against cancer cells. However, as more tumor cells are r...

2018
Zhihong Sun Cheng Zhou Feng Liu Wenchao Zhang Jing Chen Yanlong Pan Lianqing Ma Qimin Liu Yuping Du Jinbo Yang Qin Wang

Natural compounds derived from plants have been an important source of numerous clinically useful anticancer agents. Nevertheless, limited studies indicate that xanthohumol (XN), a major prenylated flavonoid in hop plants (Humulus lupulus), may possess anticarcinogenic properties. The purpose of the present study was to clarify the antitumorigenic effects and the underlying mechanism of XN on b...

2015
Kristin Zimmermann Johannes Baldinger Barbara Mayerhofer Atanas G. Atanasov Verena M. Dirsch Elke H. Heiss

In light of the emerging interplay between redox and metabolic signaling pathways we investigated the potential cross talk between nuclear factor E2-related factor 2 (Nrf2) and AMP-activated kinase (AMPK), central regulators of the cellular redox and energy balance, respectively. Making use of xanthohumol (XN) as an activator of both the AMPK and the Nrf2 signaling pathway we show that AMPK exe...

2016
Fatemeh Abdi Hamid Mobedi Nasibeh Roozbeh

Menopause is a critical stage of women's life associated with various complaints and distresses. Vasomotor symptoms (VMS), such as hot flushes, night sweats, sleep disturbances, and fatigue, are the most common menopause symptoms affecting about 50% to 80% of middle-aged women. Obviously, these symptoms, resulting from estrogen deficiency during menopause, can exert negative effects on women's ...

2016
Kai-Hua Wang Long-Jian Huang Zhen-Zhen Chen Guang-Shan Zheng Yan Lv Jian-Min Huang

Xanthohumol (XN) is a prenylated chalcone derived from hops (Humuluslupulus L.). Several studies showed that XN exhibited potent neuroprotective activity. However, the precise mechanism and effect of XN in cerebral ischemia/reperfusion (I/R) injury needs further investigations. In the present study, we investigated the role of XN in regulating oxygen-glucose deprivation/reperfusion (OGD/R)-indu...

2014
Tetsuro Yoshimaru Masato Komatsu Etsu Tashiro Masaya Imoto Hiroyuki Osada Yasuo Miyoshi Junko Honda Mitsunori Sasa Toyomasa Katagiri

Xanthohumol (XN) is a natural anticancer compound that inhibits the proliferation of oestrogen receptor-α (ERα)-positive breast cancer cells. However, the precise mechanism of the antitumour effects of XN on oestrogen (E2)-dependent cell growth, and especially its direct target molecule(s), remain(s) largely unknown. Here, we focus on whether XN directly binds to the tumour suppressor protein p...

2018
Nathaniel F. Henneman Stephanie L. Foster Micah A. Chrenek Jana T. Sellers Charles B. Wright Robin H. Schmidt John M. Nickerson Jeffrey H. Boatright

Purpose To investigate whether treatment with xanthohumol (XN), the principal prenylated chalconoid from Humulus lupulus (hops), is protective in a mouse model of light-induced retinal degeneration (LIRD). Methods Mice (129S2/SvPasCrl) were intraperitoneally injected with vehicle or XN prior to toxic light exposure and every 3 days thereafter. Retinal function was assessed by electroretinogra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید